Millipore Sigma Vibrant Logo

506174 p38 MAP Kinase Inhibitor XIX, Skepinone-L - Calbiochem

Overview

Replacement Information

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
506174-5MG
Retrieving availability...
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 5 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA cell-permeable phenylamino-dibenzosuberone-diol with a rigid molecular structure specifically designed to target hydrophobic region I in p38α & p38β, but not in other kinases with bulky entrance-blocking gatekeeper residues. Shown to selectively inhibit p38α (IC50 = 5 nM; [ATP] = 100 µM) and p38β (97% inhibition at1 µM), while exhibiting little affinity toward 400 other kinase constructs, including p38δ, p38γ, Erk1/2/3/4/5/8, JNK1/2/3, and MEK1/2/3/4/6. Shown to prevent cellular HSP27 Ser82 phosphorylation upon p38 activation by Anisomycin (Cat. No. 176880) in HeLa (IC50 = 25 nM) or by TNF-α in THP-1 cultures. Unlike the ATP-binding site-targeting BIRB 796 (Cat. No. 506172) and SB 203580 (Cat. Nos. 559389, 559395, and 559398), Skepinone-L does not inhibit JNK-mediated c-Jun or ERK-dependent CREB phosphorylation in THP-1 cultures. Oral administration to D-Gal- (Cat. No. 34539) sensitized mice is reported to greatly reduce plasma TNF-α production upon LPS (Cat. No. 437625) challenge (by 77%; 3 mg/kg p.o.) in vivo.
      Catalogue Number506174
      Brand Family Calbiochem®
      Synonyms(2-(2,4-Difluorophenylamino)-7-[2R-,3-dihydroxypropoxy]-10,11-dihydro-dibenzo[a,d]-cyclohepten-5-one)
      References
      ReferencesKoeberle, S.C., et al. 2012. J. Med. Chem. 55, 5868.
      Koeberle, S.C., et al. 2011. Nat. Chem. Biol. 8, 141.
      Product Information
      FormLight yellow powder
      Hill FormulaC₂₄H₂₁F₂NO₄
      Chemical formulaC₂₄H₂₁F₂NO₄
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥99% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      506174-5MG 04055977272406

      Documentation

      p38 MAP Kinase Inhibitor XIX, Skepinone-L - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      p38 MAP Kinase Inhibitor XIX, Skepinone-L - Calbiochem Certificates of Analysis

      TitleLot Number
      506174

      References

      Reference overview
      Koeberle, S.C., et al. 2012. J. Med. Chem. 55, 5868.
      Koeberle, S.C., et al. 2011. Nat. Chem. Biol. 8, 141.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision04-July-2013 JSW
      Synonyms(2-(2,4-Difluorophenylamino)-7-[2R-,3-dihydroxypropoxy]-10,11-dihydro-dibenzo[a,d]-cyclohepten-5-one)
      DescriptionA cell-permeable phenylamino-dibenzosuberone-diol with a rigid molecular structure specifically designed to target p38α & p38β hydrophobic region I whose access is possible due to a small gatekeeper amino acid (Thr106 in human p38α/β ), but not in other kinases with bulky entrance-blocking gatekeeper residues. Shown to selectively inhibit p38α (IC50 = 5 nM; [ATP] = 100 µM) and p38β (97% inhibition at1 µM), while being less effective against JNK3, SLK, or CAMK2D (67%, 61%, and 57% inhibition, respectively, at 1 µM) and exhibiting little or no potency toward 328 other kinase constructs (IC50 >1 µM). Likewise, binding studies reveal selective affinity toward p38α (Kd = 1.5 nM) and p38β, but not 400 other kinase constructs, including p38δ, p38γ, Erk1/2/3/4/5/8, JNK1/2/3, and MEK1/2/3/4/6. Shown to prevent cellular HSP27 Ser82 phosphorylation upon p38 activation by Anisomycin (Cat. No. 176880) in HeLa (IC50 = 25 nM) or by TNF-α in THP-1 cultures (80 nM). Unlike BIRB 796 (2 µM; Cat. No. 506172), Skepinone-L does not inhibit JNK-mediated c-Jun Ser63 phosphorylation upon TNF-α stimulation in THP-1 cells, nor does Skepinone-L affect ERK-dependent CREB Ser133 phosphorylation in THP-1 upon PMA (Cat. No. 506172) treatment, whereas SB 203580 (4 µM; Cat. Nos. 559389, 559395, and 559398) is shown to inhibit. Oral administration to D-Gal- (Cat. No. 34539) sensitized mice 1h prior to 90 min LPS (Cat. No. 437625) challenge greatly reduces plasma TNF-α production (by 77%; plasma [inhibitor] = 240 nM; 3 mg/kg p.o.) in vivo.
      FormLight yellow powder
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₄H₂₁F₂NO₄
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesKoeberle, S.C., et al. 2012. J. Med. Chem. 55, 5868.
      Koeberle, S.C., et al. 2011. Nat. Chem. Biol. 8, 141.